Overzicht van nieuwe geneesmiddelen (ATC-codes) in 2023 met de vergoeding per jaar
- Raming voor de totale Zvw-populatie
Introductiejaar | ATC-code | 2023 | 2024 |
---|---|---|---|
2023 | A05AX05 Odevixibat | 5.363.310 | 11.830.186 |
A10BX16 Tirzepatide | 140 | 894.044 | |
A16AA07 Metreleptine | 2.468.960 | 3.805.009 | |
B02BX09 Fostamatinib | 290.116 | 504.617 | |
B03AA01 Ferroglycinesulfaat | 21.570 | 748 | |
B03AB05 Ijzeroxidepolymaltose-complexen | 3.122 | 445 | |
B06AC05 Lanadelumab | 2.941.059 | 12.492.578 | |
C01DX22 Vericiguat | 1.050 | 8.574 | |
C10AX15 Bempedoinezuur | 185.316 | 850.211 | |
J05AX31 Lenacapavir | 62.834 | 59.550 | |
L04AG03 Natalizumab | 15.525 | 133.601 | |
M09AX10 Risdiplam | 4.241.940 | 18.226.611 | |
N02CC08 Lasmiditan | 31.814 | 47.152 | |
N06BA14 Solriamfetol | 9.236 | 252.325 | |
Totaal | 15.635.993 | 49.105.653 |